Cerebral Venous Thrombosis
(CVT)
Overview for Clinical Presentation
Definition
• • CVT is thrombosis of the dural venous
sinuses and/or cerebral veins
• • Leads to impaired venous drainage, raised
ICP, and venous infarction
Risk Factors
• • Prothrombotic states (Protein C/S deficiency,
Factor V Leiden)
• • Pregnancy and postpartum
• • Oral contraceptive pills
• • Infections (otitis, mastoiditis)
• • Malignancy
• • Dehydration
• • Systemic inflammatory disorders
Clinical Features
• • Headache (most common)
• • Seizures
• • Focal neurological deficits
• • Papilledema
• • Altered sensorium
• • Signs of raised intracranial pressure
Diagnosis
• • MRI with MRV – investigation of choice
• • CT Venography – fast and useful
• • D-dimer may be elevated but not diagnostic
• • Ophthalmic exam for papilledema
Treatment
• • Anticoagulation: LMWH followed by
warfarin/DOAC
• • Treat underlying cause
• • Manage raised ICP
• • Thrombolysis/endovascular therapy
(selected cases)
Prognosis
• • Generally good with early diagnosis and
treatment
• • Mortality ~5–10%
• • Seizures and neurological deficits may
persist in some patients

CVT_Presentation overview and clinical features

  • 1.
  • 2.
    Definition • • CVTis thrombosis of the dural venous sinuses and/or cerebral veins • • Leads to impaired venous drainage, raised ICP, and venous infarction
  • 3.
    Risk Factors • •Prothrombotic states (Protein C/S deficiency, Factor V Leiden) • • Pregnancy and postpartum • • Oral contraceptive pills • • Infections (otitis, mastoiditis) • • Malignancy • • Dehydration • • Systemic inflammatory disorders
  • 4.
    Clinical Features • •Headache (most common) • • Seizures • • Focal neurological deficits • • Papilledema • • Altered sensorium • • Signs of raised intracranial pressure
  • 5.
    Diagnosis • • MRIwith MRV – investigation of choice • • CT Venography – fast and useful • • D-dimer may be elevated but not diagnostic • • Ophthalmic exam for papilledema
  • 6.
    Treatment • • Anticoagulation:LMWH followed by warfarin/DOAC • • Treat underlying cause • • Manage raised ICP • • Thrombolysis/endovascular therapy (selected cases)
  • 7.
    Prognosis • • Generallygood with early diagnosis and treatment • • Mortality ~5–10% • • Seizures and neurological deficits may persist in some patients